These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22586949)

  • 21. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leprosy and Buruli ulcer: similarities suggest combining control and prevention of disability strategies in countries endemic for both diseases.
    Walsh DS; De Jong BC; Meyers WM; Portaels F
    Lepr Rev; 2015 Mar; 86(1):1-5. PubMed ID: 26065143
    [No Abstract]   [Full Text] [Related]  

  • 23. Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions.
    Schütte D; Umboock A; Pluschke G
    Br J Dermatol; 2009 Feb; 160(2):273-83. PubMed ID: 19016694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance with antimicrobial therapy for buruli ulcer.
    Klis S; Kingma R; Tuah W; Stienstra Y; van der Werf TS
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6340. PubMed ID: 25225342
    [No Abstract]   [Full Text] [Related]  

  • 25. Implementing active community-based surveillance-response system for Buruli ulcer early case detection and management in Ghana.
    Ahorlu CSK; Okyere D; Ampadu E
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006776. PubMed ID: 30208037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Buruli ulcer and the National Health Insurance Scheme in Ghana].
    Niiyama T
    Nihon Hansenbyo Gakkai Zasshi; 2012 Sep; 81(3):185-90. PubMed ID: 23012846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reply to "compliance with antimicrobial therapy for buruli ulcer".
    Phillips RO; Sarfo FS; Abass MK; Frimpong M; Ampadu E; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6341. PubMed ID: 25225343
    [No Abstract]   [Full Text] [Related]  

  • 28. Buruli ulcer: first programme review meeting for west Africa--summary report.
    Wkly Epidemiol Rec; 2009 Feb; 84(6):43-8. PubMed ID: 19198050
    [No Abstract]   [Full Text] [Related]  

  • 29. To Buruli or not to Buruli.
    Ho L; Cohn J; Comte E
    Trop Doct; 2013 Apr; 43(2):92. PubMed ID: 23796682
    [No Abstract]   [Full Text] [Related]  

  • 30. [Buruli ulcer re-emergent infection].
    Adou L
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):125-33. PubMed ID: 20422927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection).
    Walsh DS; Portaels F; Meyers WM
    Curr Opin Infect Dis; 2010 Oct; 23(5):445-55. PubMed ID: 20581668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceived causes and risk factors of Buruli ulcer among patients at Agogo Presbyterian hospital in Ashanti Region of Ghana.
    Anokye R; Acheampong E; Mprah WK; Sarpong E
    BMC Res Notes; 2018 Jan; 11(1):64. PubMed ID: 29361986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing Buruli ulcer control in Ghana through social interventions: a case study from the Obom sub-district.
    Ahorlu CK; Koka E; Yeboah-Manu D; Lamptey I; Ampadu E
    BMC Public Health; 2013 Jan; 13():59. PubMed ID: 23339623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.
    Schütte D; Um-Boock A; Mensah-Quainoo E; Itin P; Schmid P; Pluschke G
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e2. PubMed ID: 17989779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
    Yeboah-Manu D; Kpeli GS; Ruf MT; Asan-Ampah K; Quenin-Fosu K; Owusu-Mireku E; Paintsil A; Lamptey I; Anku B; Kwakye-Maclean C; Newman M; Pluschke G
    PLoS Negl Trop Dis; 2013; 7(5):e2191. PubMed ID: 23658847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Setting up a national reference laboratory for Buruli ulcer: the case of Benin.
    Affolabi D; Tanimomo-Kledjo B; Anyo G; Johnson RC; Anagonou SY; Portaels F
    Trop Med Int Health; 2008 Mar; 13(3):365-8. PubMed ID: 18397399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.
    Sopoh GE; Dossou AD; Brun LV; Barogui YT; Houézo JG; Affolabi D; Anagonou SY; Johnson RC; Kestens L; Portaels F
    Am J Trop Med Hyg; 2010 Aug; 83(2):307-13. PubMed ID: 20682873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buruli ulcer in a nine-month-old boy.
    Tsukagoshi S; Dehn TC
    Ann R Coll Surg Engl; 2012 Oct; 94(7):e215-6. PubMed ID: 23031753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of Buruli ulcer secondary prevention program in an endemic area in Côte d'Ivoire].
    Kanga JM; Kacou ED; Yao JK; Kassi K; Kouamé K; Kaloga M; Kamelan CO
    Bull Soc Pathol Exot; 2007 Oct; 100(4):277-81. PubMed ID: 17982859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tackling the worsening epidemic of Buruli ulcer in Australia in an information void: time for an urgent scientific response.
    O'Brien DP; Athan E; Blasdell K; De Barro P
    Med J Aust; 2018 Apr; 208(7):287-289. PubMed ID: 29642808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.